Cargando…
Preclinical Evidence of Paeoniflorin Effectiveness for the Management of Cerebral Ischemia/Reperfusion Injury: A Systematic Review and Meta-Analysis
Background: Vessel recanalization is the main treatment for ischemic stroke; however, not all patients benefit from it. This lack of treatment benefit is related to the accompanying ischemia-reperfusion (I/R) injury. Therefore, neuroprotective therapy for I/R Injury needs to be further studied. Paeo...
Autores principales: | Wang, Anzhu, Zhao, Wei, Yan, Kaituo, Huang, Pingping, Zhang, Hongwei, Ma, Xiaochang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032804/ https://www.ncbi.nlm.nih.gov/pubmed/35462929 http://dx.doi.org/10.3389/fphar.2022.827770 |
Ejemplares similares
-
Mechanisms and Efficacy of Traditional Chinese Medicine in Heart Failure
por: Wang, Anzhu, et al.
Publicado: (2022) -
A bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023
por: Wang, Yifei, et al.
Publicado: (2023) -
Investigating the cardioprotective effects of Fuzheng Yangxin recipe based on network pharmacology and experimental evaluation
por: Wang, Anzhu, et al.
Publicado: (2022) -
Ligustrazine Exerts Cardioprotection in Animal Models of Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms
por: Zheng, Qun, et al.
Publicado: (2018) -
Effect of tanshinone IIA for myocardial ischemia/reperfusion injury in animal model: preclinical evidence and possible mechanisms
por: Zhu, Peng-Chong, et al.
Publicado: (2023)